Literature DB >> 21333642

Hepcidin: a novel peptide hormone regulating iron metabolism.

Bhawna Singh1, Sarika Arora, Poonam Agrawal, S K Gupta.   

Abstract

BACKGROUND: Hepcidin is a low-molecular weight hepatic peptide regulating iron homeostasis. Hepcidin inhibits the cellular efflux of iron by binding to, and inducing the internalization and degradation of, ferroportin, the exclusive iron exporter in iron-transporting cells. It has been recently recognized as a main hormone behind anemia of chronic disease.
METHOD: A comprehensive literature search was conducted from the websites of Pubmed Central, the US National Library of Medicine's digital archive of life sciences literature (http://www.pubmedcentral.nih.gov/) and the National Library of Medicine (http://www.ncbl.nlm.nih.gov). The data was also assessed from journals and books that published relevant articles in this field. RESULT: Hepcidin regulates iron uptake constantly on a daily basis, to maintain sufficient iron stores for erythropoiesis. Hepcidin, by its iron regulatory action on iron metabolism may be expected to have an important role in immune regulation, inflammatory diseases and malignancies. Hepcidin is the underlying cause of anemia in these clinical settings.
CONCLUSION: Hepcidin analysis may prove to be a novel tool for differential diagnosis and monitoring of disorders of iron metabolism, and establishment of therapeutic measures in various disease conditions like hereditary hemochromatosis, anemia associated with chronic kidney disease, rheumatoid arthritis and cancers.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21333642     DOI: 10.1016/j.cca.2011.02.014

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  16 in total

1.  Association of iron metabolic enzyme hepcidin expression levels with the prognosis of patients with pancreatic cancer.

Authors:  Reishi Toshiyama; Masamitsu Konno; Hidetoshi Eguchi; Ayumu Asai; Takehiro Noda; Jun Koseki; Kei Asukai; Tomofumi Ohashi; Katsunori Matsushita; Yoshifumi Iwagami; Daisaku Yamada; Tadafumi Asaoka; Hiroshi Wada; Koichi Kawamoto; Kunihito Gotoh; Toshihiro Kudo; Taroh Satoh; Yuichiro Doki; Masaki Mori; Hideshi Ishii
Journal:  Oncol Lett       Date:  2018-03-26       Impact factor: 2.967

Review 2.  Serum hepcidin concentrations and type 2 diabetes.

Authors:  Alex Aregbesola; Sari Voutilainen; Jyrki K Virtanen; Adeola Aregbesola; Tomi-Pekka Tuomainen
Journal:  World J Diabetes       Date:  2015-07-10

3.  A Novel Isoform of the Hepatic Antimicrobial Peptide, Hepcidin (Hepc-CB1), from a Deep-Sea Fish, the Spinyjaw Greeneye Chlorophthalmus bicornis (Norman, 1939): Molecular Characterisation and Phylogeny.

Authors:  E R Chaithanya; Rosamma Philip; Naveen Sathyan; P R Anil Kumar; Swapna P Antony; V N Sanjeevan; I S Bright Singh
Journal:  Probiotics Antimicrob Proteins       Date:  2013-03       Impact factor: 4.609

4.  Molecular Characterisation and Phylogenetic Analysis of a Novel Isoform of Hepatic Antimicrobial Peptide, Hepcidin (Zc-hepc1), from the Coral Fish Moorish idol, Zanclus cornutus (Linnaeus, 1758).

Authors:  E R Chaithanya; Rosamma Philip; Naveen Sathyan; P R Anil Kumar; Sherine Sonia Cubelio; I S Bright Singh
Journal:  Probiotics Antimicrob Proteins       Date:  2013-09       Impact factor: 4.609

5.  Applied value of monitoring serum hepcidin in differential diagnosis of infection versus tumor fevers.

Authors:  Ling Li; Jiang-Guo Zhang; Man-Zhi Zhao; Zhu-Hua Wu; Jian-Xin Song
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-04-11

6.  Dysregulation of iron homeostasis and methamphetamine reward behaviors in Clk1-deficient mice.

Authors:  Peng-Ju Yan; Zhao-Xiang Ren; Zhi-Feng Shi; Chun-Lei Wan; Chao-Jun Han; Liu-Shuai Zhu; Ning-Ning Li; John L Waddington; Xue-Chu Zhen
Journal:  Acta Pharmacol Sin       Date:  2021-11-22       Impact factor: 7.169

7.  Paraoxonase-1 status in patients with hereditary hemochromatosis.

Authors:  Nicola Martinelli; Anabel García-Heredia; Helena Roca; Núria Aranda; Victoria Arija; Bharti Mackness; Michael Mackness; Fabiana Busti; Gerard Aragonès; Juan Pedro-Botet; Federica Pedica; Ivana Cataldo; Judit Marsillach; Jorge Joven; Domenico Girelli; Jordi Camps
Journal:  J Lipid Res       Date:  2013-03-06       Impact factor: 5.922

Review 8.  Targeting programmed cell death in metabolic dysfunction-associated fatty liver disease (MAFLD): a promising new therapy.

Authors:  Jianan Zhao; Yiyang Hu; Jinghua Peng
Journal:  Cell Mol Biol Lett       Date:  2021-05-07       Impact factor: 5.787

Review 9.  Hepatocytes: a key cell type for innate immunity.

Authors:  Zhou Zhou; Ming-Jiang Xu; Bin Gao
Journal:  Cell Mol Immunol       Date:  2015-12-21       Impact factor: 11.530

10.  Decreased serum hepcidin concentration correlates with brain iron deposition in patients with HBV-related cirrhosis.

Authors:  Dong Lin; Jing Ding; Jian-Ying Liu; Yi-Feng He; Zhi Dai; Cai-Zhong Chen; Wei-Zhong Cheng; Jian Zhou; Xin Wang
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.